# A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

> **NCT01302054** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 990 (actual)

## Conditions studied

- Urinary Bladder, Overactive

## Interventions

- **DRUG:** Fesoterodine 8 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01302054
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 990 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302054, "A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01302054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*